Effects of surface-modified scaffolds on the growth and differentiation of mouse adipose-derived stromal cells

Journal of Tissue Engineering and Regenerative Medicine

Volumn 1, Issue 3, 2007, Pages 211-217

  Lin, Jing ^a   Lindsey, Merry L ^a   Zhu, Beili ^b   Mauli Agrawal, C ^b   Bailey, Steven R ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b The University of Texas at San Antonio   (United States)

Author keywords

Adipose derived stromal cell; Angiogenesis; Differentiation; Gas plasma; Heart failure; Surface modified scaffolds

Indexed keywords

CELL CULTURE; CELL ENGINEERING; ENDOTHELIAL CELLS; GENE EXPRESSION; MAMMALS; POLYMERASE CHAIN REACTION; SCAFFOLDS (BIOLOGY); TISSUE;

ADIPOSE-DERIVED STROMAL CELLS; ANGIOGENESIS; CYCLOOXYGENASE 2; DIFFERENTIATION; GAS PLASMA; GROWTH MEDIUM; HEART FAILURE; MATRIX METALLOPROTEINASE-2; SURFACE-MODIFIED; SURFACE-MODIFIED SCAFFOLD;

CELL PROLIFERATION;

BIOLOGICAL MARKER; COLLAGEN; LAMININ; MATRIGEL; PROTEOGLYCAN; VASCULOTROPIN A;

ADIPOSE TISSUE; ANGIOGENESIS; ANIMAL; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CULTURE MEDIUM; CYTOLOGY; DRUG COMBINATION; GAS; GENE EXPRESSION REGULATION; METABOLISM; MOUSE; SECRETION; STEM CELL; STROMA CELL; SURFACE PROPERTY; TISSUE SCAFFOLD; VASCULARIZATION;

ADIPOSE TISSUE; ANIMALS; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; COLLAGEN; CULTURE MEDIA, CONDITIONED; DRUG COMBINATIONS; GASES; GENE EXPRESSION REGULATION; LAMININ; MICE; NEOVASCULARIZATION, PHYSIOLOGIC; PROTEOGLYCANS; STEM CELLS; STROMAL CELLS; SURFACE PROPERTIES; TISSUE SCAFFOLDS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 41949098133     PISSN: 19326254     EISSN: 19327005     Source Type: Journal    
DOI: 10.1002/term.27     Document Type: Article

References (44)

1. Bailey SR, Polan J, Morse B, et al. 2002; Angiogenic bFGF expression from gas plasma-treated scaffolds. Cardiovasc Radiat Med 3: 183-189.
2. Bailey SR, Polan J, Munoz O, Agrawal M, Goswami N. 2004; Proliferation and β-tubulin for human aortic endothelial cells within gas plasma scaffolds. Cardiovasc Radiat Med 5: 119-124.
3. Chan CML, Ma BBY, Hui EP, et al. Cyclooxygenase-2 expression in advanced nasopharyngeal carcinoma - a prognostic evaluation and correlation with hypoxia inducible factor 1α and vascular endothelial growth factor. Oral Oncol (in press).
4. Chim H, Ong J, Schantz J, Hutmacher D, Agrawal C. 2003; Efficacy of glow discharge gas plasma treatment as a surface modification process for three-dimensional poly(D,L-lactide) scaffolds. J Biomed Mater Res A 65: 327-335.
5. Ciardelli G, Chiono V, Vozzi G, et al. 2005; Blends of polycaprolactone and polysaccharides in tissue engineering applications. Biomacromolecules 6: 1961-1976.
6. De Ugarte DA, Alfonso Z, Zuk PA, et al. 2003; Differential expression of stem cell mobilization-associated molecules on multi-lineage cells from adipose tissue and bone marrow. Immunol Lett 89: 267-270.
7. Diamond MP, El-Hammady E, Munkarah A, Bieber EJ, Saed G. 2005; Modulation of the expression of vascular endothelial growth factor in human fibroblasts. Fertil Steril 83: 405-409.
8. Dragoo JL, Choi J, Lieberman J, et al. 2003a; Bone induction by BMP-2 transduced stem cells derived from human fat. J Orthopaed Res 21: 622-629.
9. Dragoo JL, Samimi B, Zhu M, et al. 2003b; Tissue-engineered cartilage and bone using stem cells from human infrapatellar fat pads. J Bone Joint Surg 85: 740-747.
10. Erickson G, Gimble J, Franklin D, et al. 2002; Chondrogenic potential of adipose tissue-derived stromal cells in vitro and in vivo. Biochem Biophys Res Commun 290: 763-769.
11. Halvorsen YD, Franklin D, Bond A, et al. 2001; Extracellular matrix mineralization and osteoblast gene expression by human adipose tissue-derived stromal cells. Tissue Eng 7: 729-741.
12. Jiro F, Hiroshi T, Eriko S, et al. 2006; Expression of cyclooxygenase-2 related to angiogenesis in uterine cervical cancers. J Biomed Sci 13: 825-832.
13. Kellar RS, Landeen L, Shepherd B, et al. 2001; Scaffold-based threedimensional human fibroblast culture provides a structural matrix that supports angiogenesis in infarcted heart tissue. Circulation 104: 2063-2068.
14. Khang G, Jeon J, Lee J, Cho S, Lee H. 1997; Cell and platelet adhesions on plasma glow discharge-treated polylactide-coglycolide. Biomed Mater Eng 7: 357-368.
15. Lee JW, Kim YH, Park KD, et al. 2004a; Importance of integrin β-1-mediated cell adhesion on biodegradable polymers under serum depletion in mesenchymal stem cells and chondrocytes. Biomaterials 25: 1901-1909.
16. Lee RH, Kim B, Choi I, et al. 2004b; Characterization and expression analysis of mesenchymal stem cells from human bone marrow and adipose tissue. Cell Physiol Biochem 14: 311-324.
17. Leor J, Aboulafia-Etzion S, Dar A, et al. 2000; Bioengineered cardiac grafts: a new approach to repair the infarcted myocardium? Circulation 102(III): 56-61.
18. Leor J, Amsalem Y, Cohen S. 2005; Cells, scaffolds, and molecules for myocardial tissue engineering. Pharmacol Therapeut 105: 151-163.
19. Li W, Xu RJ, Zhang HH, Jiang LH. 2006; Overexpression of cyclooxygenase-2 correlates with tumor angiogenesis in endometrial carcinoma. Int J Gynecol Cancer 16: 1673-1678.
20. Lin CC, Co CC, Ho CC. 2005; Micropatterning proteins and cells on polylactic acid and polylactide-co-glycolide. Biomaterials 26: 3655-3662.
21. Losordo DW, Vale P, Symes J, et al. 1998; Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia. Circulation 98: 2800-2804.
22. Mannello F. 2006; Multipotent mesenchymal stromal cell recruitment, migration, and differentiation: what have matrix metalloproteinases got to do with it? Stem Cells 24: 1904-1907.
23. Mick GJ, Wang X, McCormick K. 2002; White adipocyte vascular endothelial growth factor: regulation by insulin. Endocrinology 143: 948-953.
24. Miranville A, Heeschen C, Sengenes C, et al. 2004; Improvement of postnatal neovascularization by human adipose tissue-derived stem cells. Circulation 110: 349-355.
25. Mizuno H, Zuk P, Zhu M, et al. 2002; Myogenic differentiation by human processed lipoaspirate cells. Plastic Reconstruct Surg 109: 199-209; discussion 210-191.
26. Nathan S, Das DS, Thambyah A, et al. 2003; Cell-based therapy in the repair of osteochondral defects: a novel use for adipose tissue. Tissue Eng 9: 733-744.
27. Nguyen H, Jing Jing Q, Rajendra SB, Song L. 2003; Enhanced cell attachment and osteoblastic activity by P-15 peptide-coated matrix in hydrogels. Biochem Biophys Res Commun 311: 179-186.
28. Planat-Benard VR, Jean-Sebastien S, Beatrice C, et al. 2004; Plasticity of human adipose lineage cells toward endothelial cells: physiological and therapeutic perspectives. Circulation 109: 656-663.
29. Polan JL, Morse B, Wetherold S, et al. 2002; VEGF analysis induced by endothelialized gas plasma-treated D,L-PLA scaffolds. Cardiovasc Radiat Med 3: 176-182.
30. Rappolee DA, Iyer A, Patel Y. 1996; Hepatocyte growth factor and its receptor are expressed in cardiac myocytes during early cardiogenesis. Circ Res 78: 1028-1036.
31. Rehman J, Traktuev D, Li J, et al. 2004; Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation 109: 1292-1298.
32. Sahoo SK, Panda AK, Labhasetwar V. 2005; Characterization of porous PLGA/PLA microparticles as a scaffold for threedimensional growth of breast cancer cells. Biomacromolecules 6: 1132-1139.
33. Sarkar N, Ruck A, Kallner G, et al. 2001; Effects of intramyocardial injection of phVEGF-A165 as sole therapy in patients with refractory coronary artery disease -12-month follow-up: angiogenic gene therapy. J Int Med 250: 373-381.
34. Sasamura H, Shimizu-Hirota R, Saruta T. 2005; Extracellular matrix remodeling in hypertension. Curr Hypertens Rev 1: 51-60.
35. Suh H, Hwang Y-S, Lee J-E, Han CD, Park J-C. 2001; Behavior of osteoblasts on a type I atelocollagen grafted ozone oxidized poly-Llactic acid membrane. Biomaterials 22: 219-230.
36. Symes JF, Losordo D, Vale P, et al. 1999; Gene therapy with vascular endothelial growth factor for inoperable coronary artery disease. Ann Thorac Surg 68: 830-836; discussion 836-837.
37. Tholpady SS, Katz A, Ogle R. 2003; Mesenchymal stem cells from rat visceral fat exhibit multipotential differentiation in vitro. Anat Rec A: Discov Mol Cell Evolut Biol 272: 398-402.
38. Vacanti JP, Langer R. 1999; Tissue engineering: the design and fabrication of living replacement devices for surgical reconstruction and transplantation. Lancet 354(suppl 1): SI32-34.
39. Wickham MQ, Erickson G, Gimble J, Vail T, Guilak F. 2003; Multipotent stromal cells derived from the infrapatellar fat pad of the knee. Clin Orthopaed Rel Is there a volume number?Res 412: 196-212.
40. Winter A, Breit S, Parsch D, et al. 2003; Cartilage-like gene expression in differentiated human stem cell spheroids: a comparison of bone marrow-derived and adipose tissue-derived stromal cells. Arthrit Rheumat 48: 418-429.
41. Wu L, Jiandong D. 2004; In vitro degradation of threedimensional porous poly(D,L-lactide-co-glycolide) scaffolds for tissue engineering. Biomaterials 25: 5821-5830.
42. Zhang QX, Magovern C, Mack C, et al. 1997; Vascular endothelial growth factor is the major angiogenic factor in omentum: mechanism of the omentum-mediated angiogenesis. J Surg Res 67: 147-154.
43. Zhu Y, Chian K, Chan-Park M, Mhaisalkar P, Ratner B. 2006; Protein bonding on biodegradable poly(L-lactide-co-caprolactone) membrane for esophageal tissue engineering. Biomaterials 27: 68-78.
44. Zuk PA, Zhu M, Mizuno H, et al. 2001; Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 7: 211-228.